MKI67 and breast neoplasm: Our comprehensive ST analyses on ER+ PDXs with defined oestrogen responses, for the first time, revealed functionally and physically distinct compartments within ER+ breast tumours and demonstrated the importance of the ST_2 signature, including Ki67 expression, using the METABRIC and two other cohorts.